![SonomaEye-full-color-vector[2].png](https://static.wixstatic.com/media/bed00b_da20b9cc704044b0b048ac8ef9190470~mv2_d_3024_2195_s_2.png/v1/fill/w_177,h_123,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SonomaEye-full-color-vector%5B2%5D.png)
Retina 2
Saturday, 3/22/2025
10:00 AM - 11:30 AM
Moderators: Linda A. Lam, MD, MBA and Charles DeBoer, MD, PhD
10:00 am – 10:10 am: Betadine Ocular Toxicity: Data on Potential Antiseptic Alternatives for Intravitreal Injections. Stephen J. Smith, MD
10:10 am – 10:20 am: Diabetic Macular Edema: Update on Aflibercept 8mg and Faricimab. David Boyer, MD
10:20 am – 10:30 am: Role of Inflammation and Topical Steroids for the Treatment of Diabetic Macular Edema. Baruch D. Kuppermann, MD
10:30 am – 10:40 am: Photobiomodulation for Age Related Macular Degeneration: A New Treatment Modality for AMD. Diana Do, MD
10:40 am – 10:50 am: Update on Gene Therapy for Diabetic Retinopathy. Nikolas London, MD
10:50 am – 11:00 am: Ixoberogene Soroparvovec Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration. Glenn Yiu, MD
11:00 am – 11:10 am: Extended Drug Delivery to the Posterior Segment. Charles Meno Theodore DeBoer, MD
11:10 am – 11:30 am: Clinical Cases
Panel Discussion with all Speakers and Moderators, led by Diana Do, MD